Table 3.
Plasma TNF-α concentrations before and after control, moderate- and higher-intensity exercise in higher and lower fit groups.
| Tumor necrosis factor (pg/ml) | Time point (min) | P-value | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 0 Post | 90 Post | Time | Protocol | Group | Interactions | ||
| Lower fit | Control | 13.62 (0.67–26.57) | 13.43 (0.91–25.95) | 13.59 (−0.33–27.51) | Protocol*Time: 0.70 Protocol*Group: 0.61 Time*Group: 0.45 Protocol*Time*Group: 0.46 |
|||
| Moderate-intensity | 12.23 (1.64–22.82) | 11.96 (1.39–22.52) | 11.44 (1.73–21.15) | |||||
| Higher-intensity | 13.54 (1.01–26.07) | 13.15 (0.95–25.34) | 12.40 (1.08–23.71) | 0.26 | 0.34 | 0.33 | ||
| Higher fit | Control | 41.40 (3.70–79.14) | 38.07 (4.16–71.98) | 39.76 (1.55–77.96) | ||||
| Moderate-intensity | 43.38 (4.42–82.33) | 45.21 (3.62–86.81) | 32.78 (2.94–62.62) | |||||
| Higher-intensity | 43.21 (0.55–85.87) | 46.34 (1.84–90.85) | 43.15 (0.47–85.82) | |||||
Tumor Necrosis Factor (TNF-α) responses to seated control, moderate-intensity continuous and higher-intensity intermittent exercise protocols. Data presented are from plasma samples taken before, immediately post- and 90 min post-protocol. All data are mean (95% confidence interval).